Skip to content

Released Aug 5, 2022, before the open

10-Q filed Aug 5, 2022, 36 days after period end · 0000950170-22-014951

Q2 2022 · 10-Q
Revenue$118.07M−2.7% vs Q2 2021+10.9% vs Q1 2022
Net Income$2.49M+2.9% vs Q2 2021N/M vs Q1 2022
EPS Diluted$0.12±0.0% vs Q2 2021N/M vs Q1 2022
Gross Profit$86,470,000−8.0%
Operating Income$6,641,000+55.6%
Operating Cash Flowderived-$4,913,000N/M
Free Cash Flowderived-$10,616,000N/M
Margins · derived
Gross margin73.2%−4.2 pt vs Q2 2021
Operating margin5.6%+2.1 pt vs Q2 2021
Net margin2.1%+0.1 pt vs Q2 2021

What the release said

The release

Same quarter

MetricQ2 2022Q2 2021Q2 2020Q2 2019
Revenue$118.07M$121.39M$73.14M$115.85M
Net Income$2.49M$2.42M-$18.42M-$547.00K
EPS Diluted$0.12$0.12-$0.96-$0.03

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR